Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany
Purpose: Gene expression tests can inform decisions on whether to recommend chemotherapy for patients with HR+, HER2- early breast cancer. The goal of this analysis was to compare treatment costs by an expanded budget impact model of reimbursed gene expression tests in Germany. Methods: A cost compa...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2022-01-01
|
| Серія: | Cancer Treatment and Research Communications |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2468294222000119 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|